Discover trends, market shifts, and competitive outlooks for the hereditary cancer testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Hereditary Cancer Testing Market, and What Factors Will Drive It?

The market for hereditary cancer testing has seen significant expansion in the past few years. The market is predicted to increase from a valuation of $4.32 billion in 2024 to an estimated $4.78 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to past growth include a rise in hereditary cancer cases, genetic counseling initiatives, preventative government measures against cancer, more comprehensive insurance coverage, increased knowledge about gene-environment relations, and the presence of support groups and patient advocates.

The market size of hereditary cancer testing is projected to experience a significant upswing in the years ahead, with expectations to expand to a value of $7.37 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%. The predicted growth during the forecasted period could be tied to the broadening of targeted therapies, improvements in precision medicine, an increase in direct-to-consumer testing, worldwide health initiatives, and advancements in bioinformatics. Upcoming trends for this period include progressing genetic sequencing technologies, the rise of telemedicine and remote genetic counseling, a heightened focus on precision medicine and individualized treatments, models for assessing cancer risk, and matters of ethics and legality.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Hereditary Cancer Testing Market?

The rise in hereditary cancer incidence is predicted to propel the hereditary cancer testing market. Hereditary cancer syndromes are caused by specific gene mutations that are inherited from parents to children. Genetic screening for hereditary cancer can identify distinct, heritable gene mutations linked to disease, ensuring a thorough cancer risk assessment for patients. For instance, as per a BioMed Central article on hereditary cancer in clinical practice, released in June 2022, approximately 10% of pancreatic cancer instances have a genetic foundation. Hence, the escalating occurrence of hereditary cancer is boosting the expansion of the hereditary cancer testing market.

Which Segments in the Hereditary Cancer Testing Offer the Most Growth?

The hereditary cancer testing market covered in this report is segmented –

1) By Test Type: Multi Panel Test, Single-Site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

Subsegments:

1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels

2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp

What Are the Fastest-Growing Geographies in the Hereditary Cancer Testing Market?

North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Hereditary Cancer Testing Industry?

Advances in technology are a rising trend drawing attention in the inherited cancer testing market. Major players in the sector are concentrating on technological advancements to maintain their market relevance. For instance, Myriad Genetics, an American firm specializing in genetic testing and precision medicine, released a genomic test with a Polygenic Breast Cancer Risk Assessment Score for all ancestries in March 2022. The company’s MyRisk Hereditary Cancer test equipped with RiskScore provides a custom breast cancer risk evaluation to all females never diagnosed with breast cancer, irrespective of their ancestral lineage.

View the full report here:

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

What Are the Key Elements That Define the Hereditary Cancer Testing Market?

The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.